NCT06536647

Brief Summary

Remote photoplethysmography (rPPG) is a camera-based method that enables contactless measurement of variation in light absorbance by haemoglobin as reflected by the changes in skin colour/pixel intensity unperceivable by human eyes. Beat-to-beat variation of light-absorbance can be used to estimate the change in the arterial blood volume underneath the skin and different vital signs including the blood pressure, heart rate, respiratory rate and oxygen saturation (SpO2) of the patient. The investigators propose an observational prospective study to independently evaluate the accuracy of contactless vital sign measurements using a cell phone-based remote photoplethysmography (rPPG) technology. This study will recruit adult patients presenting to the Accident and Emergency Department (A\&E) of Queen Mary Hospital (QMH) between 1 August 2024 and 30 October 2024. The study will be divided into 2 stages. In the initial run-in period, the investigators will collect facial video data from 200 patients to calibrate the VitalsTM system in the A\&E environment. Then, the investigators will evaluate the accuracy of the VitalsTM in estimating vital signs of 1,000 ambulatory patients in the A\&E setting. A trained research nurse and research assistant will be deployed from 09:00 to 17:00 on weekdays to screen for eligible patients in the A\&E waiting hall and to recruit patient participants throughout the study period. In this study, the investigators will only recruit triage category 3 (semi-urgent) to 5 (non-urgent) patients who are clinically stable and evaluate the performance of the VitalsTM in a designated room in A\&E. Written informed consent will be obtained from all patient participants after an explanation of the details of the study, including the rationale, benefits and risks of participation. After informed consent, contactless and manual measurement of patient blood pressure, heart rate, respiratory rate, body temperature and SpO2 will be carried out simultaneously in a designated room in A\&E. A mounted light emitting diode (LED) will be used as the light source. Facial video of the patient participant will be captured using an iPhone, an iPad and a thermal camera placed at around 50 cm from the patient. A reference object for thermal and visual imaging will be placed at the background. Also, ambient temperature and light intensity will be measured. The patient will be asked to sit down and remain still during video-recording. Manual measurement will be performed simultaneously by a trained research nurse or research assistant using standard hospital device or other medical-grade devices. A software program will be used to log vital sign measurements and recordings simultaneously so that data can be synchronised to reduce variations. The primary outcome is the accuracy of the VitalsTM platform in estimating patient heart rate measured in intraclass correlation coefficient (ICC). The investigators will also measure of accuracy of the VitalsTM platform in estimating other vital signs, including blood pressure, respiratory rate, SpO2 and body temperature. The investigators will also evaluate patient satisfaction and comfort with the contactless and manual measurement techniques. The accuracy of contactless measurement will be determined by calculating the ICC from the manual measurement readings as the ground truths. The investigators will also calculate the root mean square error (RMSE) and Pearson correlation between the contactless and manual measurement readings for individual vital signs. Altman Bland plot will be used to evaluate the bias and limits of agreement between two vital sign measurement methods.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 5, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 23, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 16, 2025

Status Verified

July 1, 2024

Enrollment Period

1.3 years

First QC Date

July 19, 2024

Last Update Submit

January 14, 2025

Conditions

Keywords

PhotoplethysmographyVital SignsEmergency departmentTriage

Outcome Measures

Primary Outcomes (1)

  • The accuracy of patient heart rate estimation

    The accuracy of the VitalsTM platform in estimating patient heart rate measured in intraclass correlation coefficient compared to manual heart rate measurement

    0 hour post-manual measurement

Secondary Outcomes (7)

  • The accuracy of patient systolic blood pressure estimation

    0 hour post-manual measurement

  • The accuracy of patient diastolic blood pressure estimation

    0 hour post-manual measurement

  • The accuracy of patient respiratory rate estimation

    0 hour post-manual measurement

  • The accuracy of patient SpO2 estimation

    0 hour post-manual measurement

  • The accuracy of patient body temperature estimation

    0 hour post-manual measurement

  • +2 more secondary outcomes

Interventions

Contactless measurement of the patient blood pressure, heart rate, respiratory rate, body temperature and SpO2 will be carried out using the VitalsTM platform based on facial video data.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with a triage category 3 (semi-urgent) to 5 (non-urgent) rating who are clinically stable in the emergency department.

You may qualify if:

  • age \>/= 18 years
  • a valid written consent

You may not qualify if:

  • age \< 18 years
  • refusal of consent/pre-existing mental illness rending consent impossible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Accident and Emergency Department, Queen Mary Hospital

Hong Kong, None Selected, Hong Kong

RECRUITING

Accident and Emergency Department, Queen Mary Hospital

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Rex Pui Kin Lam, MBBS, FHKCEM

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rex Pui Kin Lam, MBBS, FHKCEM

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2024

First Posted

August 5, 2024

Study Start

September 23, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

January 16, 2025

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Facial video data cannot be shared with other researchers according to the local patient privacy ordinance. Vital signs data from different measurement methods can be shared with other researchers upon reasonable request and after additional approval from the institutional review board.

Locations